Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
ACS Medicinal Chemistry Letters|August 25, 2020
Stereochemical Differences in Fluorocyclopropyl Amides Enable Tuning of Btk Inhibition and Off-Target ActivityJames J Crawford, Wendy Lee, Adam R Johnson, et al.
The Journal of Clinical Endocrinology and Metabolism|March 8, 2025
Adult Growth Hormone Deficiency, Replacement Therapy, and Outcomes in Long-Term Childhood Cancer SurvivorsTomoko Yoshida, Jessica L Baedke, Huiqi Wang, et al.
Nature Communications|July 4, 2025
Interconnected nanoconfining pore networks enhance catalyst CO2 interaction in electrified reactive captureHengzhou Liu, Lun An, Peiyao Wang, et al.
Cancer Cell|March 22, 2016
Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2Scott A Foster, Daniel M Whalen, Ayşegül Özen, et al.
Cell|August 30, 2008
Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodiesKim Newton, Marissa L Matsumoto, Ingrid E Wertz, et al.
ACS Chemical Biology|August 30, 2016
Battling Btk Mutants With Noncovalent Inhibitors That Overcome Cys481 and Thr474 MutationsAdam R Johnson, Pawan Bir Kohli, Arna Katewa, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Pyridones as Highly Selective, Noncovalent Inhibitors of T790M Double Mutants of EGFRMarian C Bryan, Daniel J Burdick, Bryan K Chan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 21, 2022
Preclinical development of ZED8, an 89Zr immuno-PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapyAnnie Ogasawara, James R Kiefer, Herman Gill, et al.
Pageof 11